Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 120.52% | 147.77% | -16.79% | -48.71% | -48.26% |
| Total Depreciation and Amortization | -5.09% | -9.63% | -12.33% | -6.65% | -4.02% |
| Total Amortization of Deferred Charges | -14.09% | -14.09% | -5.58% | -5.58% | -5.58% |
| Total Other Non-Cash Items | -31.89% | -41.59% | 154.71% | 127.14% | 114.68% |
| Change in Net Operating Assets | 139.16% | -457.94% | -16.18% | -395.04% | -16,199.25% |
| Cash from Operations | 34.37% | 1.57% | 11.33% | -18.18% | -17.21% |
| Capital Expenditure | -8.11% | 6.95% | 42.72% | 47.84% | 53.48% |
| Sale of Property, Plant, and Equipment | -100.00% | 88.68% | 194.86% | 194.86% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.69% | 191.23% | 542.97% | 316.74% | 181.65% |
| Cash from Investing | -76.22% | 48.30% | 75.84% | 73.48% | 81.74% |
| Total Debt Issued | -- | -- | 73.68% | -- | 60.00% |
| Total Debt Repaid | 3.85% | -89.61% | -102.06% | 2.04% | 49.27% |
| Issuance of Common Stock | 86.11% | 55.82% | -5.88% | -31.39% | -30.02% |
| Repurchase of Common Stock | 81.92% | 80.93% | 39.16% | -156.87% | -230.59% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.23% | 0.94% | 1.60% | 1.48% | 0.61% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 62.13% | 33.39% | -1.26% | -21.05% | -39.45% |
| Foreign Exchange rate Adjustments | -122.85% | -118.81% | 195.56% | 344.39% | -51.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 581.64% | 886.30% | 9,058.81% | -109.85% | -209.52% |